Cabaletta Bio

CABA

CABA Cabaletta Bio NASDAQ
Add to watchlist
--
At close :
--
  • Post market
    • Summary
    Financials
    News
    Filings
    Profile
    CABA Chart
    See on advanced chart >

    About

    Cabaletta Bio, Inc. were incorporated under the laws of the State of Delaware in April 2017. The company is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies that have the potential to provide a...
    Read More
    • Highlight
      A clinical-stage biotech company focused on targeted cell therapies for autoimmune diseases
      • Industry
      Biotechnology
    • Exchange
      NASDAQ
    • Listing Date
      10/25/2019
    • Established Date
      Invalid Date
    • Full-time Employees
      101
    • Address
      2929 Arch Street Suite 600 Philadelphia PA 19104
    • Tel
      1-267-7593100
    • Website
      www.cabalettabio.com
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock